Dorji Phuntsho, Raval Vishal, Jalali Subhadra, Sahoo Niroj, Padhi Tapas Ranjan, Kaliki Swathi, Das Anthony Vipin
Smt. Kanuri Santhamma Center for Vitreo-Retinal Diseases, L V Prasad Eye Institute, Hyderabad, Telangana, 500034, India.
Department of Retina and Vitreous, KVC Campus, LV Prasad Eye Institute, Vijayawada, India.
Int Ophthalmol. 2023 Feb;43(2):531-540. doi: 10.1007/s10792-022-02451-x. Epub 2022 Aug 20.
To study the clinical profile, treatment, and visual outcome of patients with Coats disease in India.
This was a cross-sectional, observational hospital-based study of patients diagnosed with Coats disease during a 10-year period using an electronic medical record system.
We identified 675 patients with Coats disease with a prevalence rate of 0.025%. The mean age of the patients was 16.8 years (median, 12 years). Majority were males (75%) with unilateral presentation (98%) in first decade of life (n = 309, 46%). The most common presentation was foveal exudation (stage 2B, n = 161, 23.3%), followed by exudative retinal detachment-extrafoveal (stage 3A1, n = 143, 20.7%), and extrafoveal exudation (stage 2A, n = 136, 19.7%). Treatment modalities included observation (48 eyes, 17%), laser photocoagulation ± intravitreal bevacizumab/triamcinolone acetonide (n = 82, 29%), cryotherapy ± intravitreal bevacizumab/triamcinolone acetonide (n = 64, 23%), and surgical intervention (n = 86, 31%). Despite appropriate treatment, at mean follow-up of 16 months, there was no significant difference between presenting and final visual acuity (48% vs. 48%, p > 0.05). Using multivariate regression analysis, factors associated with poor visual outcome were younger age (< 0.001; - 0.02 to - 0.1), unilateral disease (0.04; - 0.68 to - 0.01), cataract (0.004; 0.13 to 0.69), retinal detachment (< 0.001; 0.49 to 0.82), and glaucoma (< 0.001; 0.34 to 0.94).
The most common clinical presentation of Coats disease in India is foveal exudation in first and second decade. At initial presentation, about half of the affected eyes had blindness and one-third underwent surgical intervention.
研究印度Coats病患者的临床特征、治疗方法及视力预后。
这是一项基于医院的横断面观察性研究,利用电子病历系统对10年间诊断为Coats病的患者进行研究。
我们共识别出675例Coats病患者,患病率为0.025%。患者的平均年龄为16.8岁(中位数为12岁)。大多数为男性(75%),在生命的第一个十年单侧发病(98%)(n = 309,46%)。最常见的表现是黄斑部渗出(2B期,n = 161,23.3%),其次是渗出性视网膜脱离-黄斑外(3A1期,n = 143,20.7%)和黄斑外渗出(2A期,n = 136,19.7%)。治疗方式包括观察(48只眼,17%)、激光光凝联合玻璃体内注射贝伐单抗/曲安奈德(n = 82,29%)、冷冻治疗联合玻璃体内注射贝伐单抗/曲安奈德(n = 64,23%)以及手术干预(n = 86,31%)。尽管进行了适当治疗,但平均随访16个月时,初诊视力与最终视力之间无显著差异(48%对48%,p>0.05)。使用多因素回归分析,与视力预后不良相关的因素包括年龄较小(<0.001;-0.02至-0.1)、单侧疾病(0.04;-0.68至-0.01)、白内障(0.004;0.13至0.69)、视网膜脱离(<0.001;0.49至0.82)和青光眼(<0.001;0.34至0.94)。
印度Coats病最常见的临床表现是第一和第二个十年的黄斑部渗出。初诊时约一半患眼失明,三分之一接受了手术干预。